HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Saburo Sone Selected Research
Saburo Sone Research Topics
Disease
54
Neoplasms (Cancer)
06/2019 - 02/2002
34
Lung Neoplasms (Lung Cancer)
06/2019 - 02/2002
25
Neoplasm Metastasis (Metastasis)
01/2014 - 07/2002
15
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2013 - 02/2002
15
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2012 - 07/2002
10
Pleural Effusion (Pleural Effusions)
08/2012 - 02/2002
8
Rheumatoid Arthritis
03/2014 - 09/2002
8
Inflammation (Inflammations)
12/2013 - 02/2003
8
Malignant Mesothelioma
06/2013 - 01/2006
7
Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2013 - 06/2003
5
Asthma (Bronchial Asthma)
12/2013 - 02/2002
5
Fibrosis (Cirrhosis)
03/2012 - 02/2005
5
Adenocarcinoma of Lung
11/2008 - 07/2002
5
Malignant Pleural Effusion
02/2007 - 02/2002
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2012 - 01/2006
3
Body Weight (Weight, Body)
01/2013 - 03/2003
3
Idiopathic Pulmonary Fibrosis
03/2012 - 02/2005
3
Pneumonia (Pneumonitis)
01/2012 - 06/2003
3
Mesothelioma
10/2011 - 10/2007
3
Neoplasm Micrometastasis
07/2011 - 03/2003
3
Adenocarcinoma
07/2010 - 01/2006
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2008 - 11/2003
2
Respiratory Hypersensitivity
12/2013 - 01/2009
2
Radiation Pneumonitis
07/2010 - 06/2003
2
Multiple Myeloma
06/2009 - 01/2009
2
Chronic Hepatitis C
12/2007 - 02/2007
2
Infections
06/2007 - 02/2007
2
Prostatic Neoplasms (Prostate Cancer)
10/2005 - 04/2004
Drug/Important Bio-Agent (IBA)
16
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2012 - 03/2002
15
Tyrosine Kinase Inhibitors
IBA
09/2012 - 05/2003
15
ErbB Receptors (EGF Receptor)
IBA
09/2012 - 01/2003
11
Cytokines
IBA
03/2014 - 02/2002
11
Gefitinib (Iressa)
FDA Link
09/2012 - 05/2003
8
Phosphotransferases (Kinase)
IBA
09/2012 - 01/2004
7
Bleomycin (Blenoxane)
FDA Link
Generic
10/2013 - 02/2005
6
Erlotinib Hydrochloride (CP 358,774)
FDA Link
03/2012 - 11/2008
5
Parathyroid Hormone-Related Protein
IBA
01/2014 - 02/2004
5
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2006 - 03/2002
5
Proteins (Proteins, Gene)
FDA Link
08/2005 - 03/2003
4
indium-bleomycin
IBA
10/2013 - 02/2005
4
Neutralizing Antibodies
IBA
09/2012 - 02/2004
4
Tyrosine (L-Tyrosine)
FDA Link
07/2011 - 01/2005
4
Monoclonal Antibodies
IBA
10/2010 - 06/2003
4
Diphosphonates (Bisphosphonates)
IBA
01/2009 - 01/2003
3
Interleukin-8 (Interleukin 8)
IBA
01/2018 - 01/2004
3
Thymidine Phosphorylase
IBA
01/2017 - 09/2012
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2014 - 01/2004
3
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
09/2012 - 01/2006
3
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
08/2012 - 12/2007
3
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
03/2012 - 11/2008
3
Steroids
IBA
01/2012 - 02/2003
3
Imatinib Mesylate (Gleevec)
FDA Link
09/2011 - 06/2005
3
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
09/2011 - 06/2003
3
Interferon-beta
IBA
06/2009 - 02/2005
3
Therapeutic Uses
IBA
01/2009 - 12/2005
3
YM 529
IBA
01/2009 - 01/2003
3
vandetanib (ZD6474)
IBA
06/2008 - 12/2005
3
Transforming Growth Factor beta (TGF-beta)
IBA
12/2007 - 01/2005
3
Complementary DNA (cDNA)
IBA
06/2007 - 05/2003
3
src-Family Kinases
IBA
09/2006 - 01/2005
3
N- (2- chloro- 5- methoxyphenyl)- 6- methoxy- 7- ((1- methyl- 4- piperidinyl) methoxy) 4-quinazolinamine
IBA
09/2006 - 01/2005
3
Oxygen (Dioxygen)
IBA
04/2006 - 07/2002
3
CD13 Antigens (Alanine Aminopeptidase)
IBA
11/2003 - 02/2002
3
Matrix Metalloproteinases (MMPs)
IBA
03/2003 - 10/2002
2
Indicators and Reagents (Reagents)
IBA
06/2019 - 08/2005
2
Enzymes
IBA
01/2017 - 02/2007
2
Cyclin-Dependent Kinase Inhibitor p16
IBA
04/2015 - 11/2010
2
CC Chemokines
IBA
12/2013 - 12/2003
2
orantinib (SU6668)
IBA
08/2012 - 09/2011
2
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
01/2012 - 12/2006
2
Antibodies
IBA
12/2011 - 01/2009
2
Acids
IBA
10/2011 - 03/2010
2
Docetaxel (Taxotere)
FDA Link
08/2011 - 03/2003
2
lenvatinib
IBA
07/2011 - 12/2009
2
Antigens
IBA
06/2009 - 02/2002
2
Membrane Proteins (Integral Membrane Proteins)
IBA
06/2009 - 01/2009
2
Bone Marrow Stromal Antigen 2
IBA
06/2009 - 01/2009
2
NF-kappa B (NF-kB)
IBA
01/2009 - 05/2006
2
Interferons
IBA
01/2009 - 02/2005
2
N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamide
IBA
01/2009 - 05/2006
2
Zoledronic Acid (Zometa)
FDA Link
01/2009 - 01/2009
2
I-kappa B Kinase
IBA
01/2009 - 05/2006
2
Bevacizumab (Avastin)
FDA Link
01/2009 - 10/2007
2
Ligands
IBA
11/2008 - 02/2005
2
reveromycin A
IBA
12/2007 - 12/2005
2
Interferon Type I
IBA
12/2007 - 02/2007
2
Cathepsin G
IBA
02/2007 - 12/2006
2
Chemotactic Factors
IBA
02/2007 - 02/2002
2
anilinoquinazoline
IBA
09/2006 - 06/2005
2
Cisplatin (Platino)
FDA Link
Generic
03/2006 - 11/2004
2
Asbestos
IBA
03/2006 - 01/2006
2
Myosins (Myosin)
IBA
01/2006 - 09/2002
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2006 - 12/2005
2
Anti-Bacterial Agents (Antibiotics)
IBA
12/2005 - 05/2003
2
Epidermal Growth Factor (EGF)
IBA
12/2005 - 02/2003
Therapy/Procedure
30
Therapeutics
06/2019 - 02/2002
9
Drug Therapy (Chemotherapy)
08/2011 - 05/2003
4
Radiotherapy
01/2011 - 06/2003
4
Immunotherapy
06/2009 - 02/2002
3
Molecular Targeted Therapy
01/2011 - 06/2010